Electrostatic Charge-Mediated Apoptotic Vesicle Biodistribution Attenuates Sepsis by Switching Neutrophil NETosis to
Qianmin Ou1, Lingping Tan1, Yiting Shao1
1South China Center of Craniofacial Stem Cell Research, Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Abstract:
Mesenchymal stem cell (MSC) therapy can attenuate organ damage and reduce mortality in sepsis; however, the detailed mechanism is not fully elucidated. In this study, it is shown that MSC-derived apoptotic vesicles (apoVs) can ameliorate multiple organ dysfunction and improve survival in septic mice. Mechanistically, it is found that tail vein-infused apoVs mainly accumulate in the bone marrow of septic mice via electrostatic charge interactions with positively charged neutrophil extracellular traps (NETs). Moreover, apoVs switch neutrophils NETosis to apoptosis via the apoV-Fas ligand (FasL)-activated Fas pathway. In summary, these findings uncover a previously unknown role of apoVs in sepsis treatment and an electrostatic charge-directed target therapeutic mechanism, suggesting that cell death is associated with disease development and therapy.
Insights
Mesenchymal stem cell-derived apoptotic vesicles (apoVs) treat sepsis by targeting neutrophils in bone marrow. ApoVs induce neutrophil apoptosis via electrostatic interactions and the Fas pathway, improving survival in septic mice.
Area of Science:
- Immunology
- Cell Biology
- Regenerative Medicine
Background:
- Sepsis causes organ damage and mortality.
- Mesenchymal stem cell (MSC) therapy shows promise in sepsis treatment.
- The precise mechanisms of MSC therapy in sepsis remain unclear.
Purpose of the Study:
- To investigate the therapeutic potential of MSC-derived apoptotic vesicles (apoVs) in sepsis.
- To elucidate the underlying mechanisms of apoV action in sepsis treatment.
Main Methods:
- Septic mouse model.
- Tail vein infusion of apoVs.
- Analysis of apoV distribution and interaction with neutrophils.
- Investigation of the Fas ligand (FasL)-Fas pathway.
Main Results:
- ApoVs ameliorated multiple organ dysfunction and improved survival in septic mice.
- ApoVs accumulated in the bone marrow of septic mice through electrostatic interactions with neutrophil extracellular traps (NETs).
- ApoVs induced neutrophil apoptosis by activating the apoV-FasL-Fas pathway, shifting NETosis to apoptosis.
Conclusions:
- MSC-derived apoVs represent a novel therapeutic strategy for sepsis.
- Electrostatic charge-directed interactions mediate apoV targeting to NETs in bone marrow.
- The apoV-FasL-Fas pathway is crucial for the therapeutic effects of apoVs in sepsis.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway


